NuPulse Voyage™
The first minimally invasive, long-term cardiac assist device that allows for ambulation and discharge home.
Working to transform the treatment of chronic heart failure
Meet Pam
A NuPulse Trial Patient
The NuPulse Difference
NuPulse is working to radically change the management and treatment of chronic heart failure. The NuPulse Voyage is the only minimally invasive heart pump that allows patients to be discharged home, where they can recover, adjust to medications and carry on with their daily lives.
These achievements were demonstrated in patients in an early feasibility study.
These achievements were demonstrated in patients in an early feasibility study.
The NuPulse Treatment Approach
Unlike other heart pumps available and under development, the NuPulse Voyage is the only pump that works on the physiological principles of counterpulsation.
Other pumps do serve an unmet clinical need, especially in the cardiogenic shock population.
Other pumps do serve an unmet clinical need, especially in the cardiogenic shock population.
The Voyage is targeted at a different patient population – those patients with chronic heart failure.
Meet Tom
A NuPulse Trial Patient
The Innovative NuPulse Voyage™
As shown in this illustration (right), with the NuPulse Voyage, a patient is no longer tethered to a 100-pound console but instead uses a 5-pound portable device that allows for complete and unrestricted movement.
The NP Voyage operates on the same principles of counterpulsation as an intra-aortic balloon pump.
A pump is placed in the descending aorta and inflated and deflated to help move blood through the body. The pump is placed through an incision in the shoulder region of the patient and delivered through the axillary artery.
The NP Voyage operates on the same principles of counterpulsation as an intra-aortic balloon pump.
A pump is placed in the descending aorta and inflated and deflated to help move blood through the body. The pump is placed through an incision in the shoulder region of the patient and delivered through the axillary artery.
Caution-Investigational Device, Limited by United States Law to Investigational Use. Not Available for Sale.
NuPulse Drive Unit
Voyage Blood Pump™
External Real-Time
EKG Patch
EKG Patch
(Proprietary and Patented)
Clinical Results – NuPulse Voyage
NuPulse conducted an 81 patient Early Feasibility Study that involved implants in 3 distinct cohorts of patients.
The first cohort were hospitalized patients in UNOS status 1 and urgently needed a heart.
The second cohort were patients who needed a heart but needed to resolve an underlying issue, such as cessation of smoking or losing weight. These patients were implanted, sent home and brought back once they were eligible for a transplant.
The third cohort were patients who were gravely ill and had no other options.
The first cohort were hospitalized patients in UNOS status 1 and urgently needed a heart.
The second cohort were patients who needed a heart but needed to resolve an underlying issue, such as cessation of smoking or losing weight. These patients were implanted, sent home and brought back once they were eligible for a transplant.
The third cohort were patients who were gravely ill and had no other options.
Results from the feasibility trial of the NuPulse Voyage were promising and validate the launch of a pivotal trial to support potential market approval.
Meet Terrie
Before implantation, Terrie (pictured far right), was too ill to travel. After a receiving the NuPulse Voyage, Terrie was able to travel to Europe and meet his grandson for the first time.
A NuPulse Trial Patient
Patient Testimonials
The NuPluse Voyage was evaluated in a feasibility study
involving 81 patients.
Here are some personal stories of patient’s who used NuPulse Voyage while waiting for a heart transplant.
Here are some personal stories of patient’s who used NuPulse Voyage while waiting for a heart transplant.
Hear Karen Story
Participant in NuPulse Voyage feasibility study
Karen Seliga
Why sit around when you’re waiting for that heart transplant when you can get up and go!
Hear Thomas Story
Participant in NuPulse Voyage feasibility study
Thomas Gnadt
I think I’m a better transplant candidate because I’m moving and getting my heart up to its maximum potential before the transplant.
Hear Pam Story
Participant in NuPulse Voyage feasibility study
Pam Morris
I can walk around... I’m breathing well. All things are well. We’re just waiting now. Waiting for that heart to come.
Hear Rob Story
Participant in NuPulse Voyage feasibility study
Rob Gentile
It was a bridge to transplant.
Without that bridge I wouldn’t have made it.
Without that bridge I wouldn’t have made it.
Next Steps
NuPulse is now preparing for the launch of a pivotal trial to support
NuPulse Voyage market approval.
NuPulse Voyage market approval.
News & Events